drugset / Trial / NCT00005106
A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients
Parallel-groupTreatment
Summary
The purpose of this study is to look at the effects of different anti-HIV drug combinations on body fat changes in HIV-positive patients who have never received anti-HIV therapy before.
Timeline
- Start
- 1999-09
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abacavir | Other / unclassified | 300 mg | — |
| Subject | Nelfinavir | Other / unclassified | 1250 mg | — |
| Subject | Stavudine | Other / unclassified | 40 mg | — |
| Subject | Zidovudine | Small molecule | 300 mg | — |
| Background | Lamivudine | Other / unclassified | 150 mg | — |